These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3147465)

  • 1. Modulation of prostacyclin synthetase by cicletanine and drugs which affect ion transport.
    Deby C; Bourgain RH; Andries R; Braquet P
    Pharmacol Res Commun; 1988 Sep; 20 Suppl 3():101-8. PubMed ID: 3147465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of prostacyclin generation by cicletanine (an in vivo investigation).
    Bourgain RH; Deby C
    Drugs Exp Clin Res; 1988; 14(2-3):135-9. PubMed ID: 3138096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of cicletanine on prostacyclin generation in vivo].
    Bourgain RH; Deby C; Andries R
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():33-6. PubMed ID: 2514665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Increase of the prostacyclin/thromboxane A2 ratio in the plasma of rabbits treated with cicletanine, a new antihypertensive agent].
    Deby C; Deby-Dupont G; Braquet P; Bourgain R; Pincemail J; Bosquet D
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():97-9. PubMed ID: 3142438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exchange of cyclooxygenase dependent metabolites between vessel wall and platelets in arterial thrombosis.
    Bourgain RH; Andries R; Decuyper K; Braquet P
    Thromb Res; 1988 May; 50(3):401-8. PubMed ID: 3134741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of in vivo generation of prostanoids by drugs affecting membrane ion transport.
    Deby C; Bourgain RH; Deby-Dupont G; Pincemail J; Garay RP; Braquet P
    Drugs Exp Clin Res; 1988; 14(2-3):123-34. PubMed ID: 3138095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostacyclin mediates arachidonic acid-induced relaxation of rabbit isolated mesenteric arteries.
    Trachte GJ
    J Cardiovasc Pharmacol; 1986; 8(4):758-64. PubMed ID: 2427815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mechanical stress increases sodium ion content in vascular smooth muscle cells through a calcium-dependent pathway: prevention by cicletanine via a cyclo-oxygenase product.
    Rosati C; Cavalier S; Braquet P; Berthet P; Tarrade T; Ruchoux MM; Garay R
    J Hypertens Suppl; 1989 Dec; 7(6):S322-3. PubMed ID: 2561148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cicletanine and eicosanoids in cultured vascular smooth muscle cells.
    Dorian B; Daret D; Braquet P; Larrue J
    Drugs Exp Clin Res; 1988; 14(2-3):117-22. PubMed ID: 3138094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effects of cicletanine and renal protection in Dahl salt-sensitive rats.
    Uehara Y; Numabe A; Hirawa N; Kawabata Y; Iwai J; Ono H; Matsuoka H; Takabatake Y; Yagi S; Sugimoto T
    J Hypertens; 1991 Aug; 9(8):719-28. PubMed ID: 1655882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of treatment with cicletanine on kidney PGE2 and PGI1 in spontaneously hypertensive rats].
    Deby C; Deby-Dupont G; Droy-Lefaix MT; Bosquet D; Berthet P; Bakri F
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():37-40. PubMed ID: 2514666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between cicletanine and the eicosanoid system in human subcutaneous resistance arteries.
    Calder JA; Schachter M; Sever PS
    J Pharm Pharmacol; 1992 Jul; 44(7):574-8. PubMed ID: 1357137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of prostacyclin synthesis in cultured aortic smooth muscle cells by 'diuretic-antihypertensive' drugs.
    Dorian B; Larrue J; Defeudis FV; Salari H; Borgeat P; Braquet P
    Biochem Pharmacol; 1984 Jul; 33(14):2265-9. PubMed ID: 6431978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ionic perturbations produced by a non-laminar flow in vascular smooth muscle cells in culture. Protection by cicletanine via a cyclo-oxygenase metabolite].
    Rosati C; Cavalier S; Braquet P; Berthet P; Tarrade T; Ruchoux MM; Garay R
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():41-4. PubMed ID: 2514667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General pharmacology of cicletanine.
    Clostre F; Etienne A
    Drugs Exp Clin Res; 1988; 14(2-3):73-82. PubMed ID: 3416726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cicletanine on prostaglandin I2 and E2 levels in patients with essential hypertension.
    Yasu T; Imanishi M
    Am J Hypertens; 1997 Jul; 10(7 Pt 1):750-5. PubMed ID: 9234829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reduction of kidney prostaglandin synthesis in patients with essential hypertension. Stimulating effect of cicletanine].
    Hornych A; Boisson J; Gaschard JC
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():85-90. PubMed ID: 2514674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human lymphocytes stimulate prostacyclin synthesis in human umbilical vein endothelial cells. Involvement of endothelial cPLA2.
    Merhi-Soussi F; Dominguez Z; Macovschi O; Dubois M; Savany A; Lagarde M; Prigent AF
    J Leukoc Biol; 2000 Dec; 68(6):881-9. PubMed ID: 11129656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive profile of cicletanine, a furopyridine derivative: comparison with captopril, indapamide and prazosin.
    Malherbe E; Auguet M; Delaflotte S; Le Hégarat M; Baranes J; Clostre F; Braquet P
    Pharmacol Res Commun; 1988 Sep; 20 Suppl 3():121-33. PubMed ID: 2976170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the mechanism of action of the antihypertensive agent cicletanine.
    Castro A; Parra L; Fuentes JA
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():51-4. PubMed ID: 2514669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.